Sparlin® (Sparfloxacin) is a synthetic, broad-spectrum antibacterial agent from the fluoroquinolone family. It has been reported to be more active in vitro than other fluoroquinolones against some Gram positive organisms (such as Streptococcus pneumoniae and Staphylococcus aureus), Mycobacteria and Chlamydia spp. Sparlin® (Sparfloxacin) is indicated for the treatment of the following infections due to susceptible microorganisms: Upper & lower respiratory tract infections including sinusitis, acute exacerbation of chronic bronchitis, community acquired and hospital acquired pneumonia. Urinary tract infections including gonococcal and non-gonococcal urethritis, chancroid and other sexually transmitted diseases. Skin and soft tissue infections. Prophylactic use in different urological and ophthalmic operations.